The Lancet: October 24, 2008

The Lancet in conversation with - A podcast by The Lancet Group - Fridays

Categories:

Ludwig Kappos discusses a phase II study which suggests that oral fumarate may have a future role in the treatment of multiple sclerosis.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv